Past informs the future: outcomes post allogeneic stem cell transplantation in high risk chronic lymphocytic leukaemia (CLL)

被引：0
|
作者：
Bennett, Rory
Frawley, Thomas
Khot, Amit
Thompson, Phillip
Anderson, Mary Ann
Ritchie, David
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553104
引用
收藏
页码：S153 / S154
页数：2
相关论文
共 50 条
  • [41] Effects of rituximab given for relapse of chronic lymphocytic leukaemia after allogeneic stem cell transplantation: an EBMT survey
    Dreger, P
    Schetelig, J
    Corradini, P
    Selleslag, D
    Nagler, A
    Hegenbart, U
    Casini, M
    Zachee, P
    van Biezen, A
    Michallet, M
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 2006, 37 : S228 - S228
  • [42] Autologous stem cell transplantation in chronic lymphocytic leukaemia:: the Finnish experience
    Jantunen, E
    Itälä, M
    Siitonen, T
    Koivunen, E
    Juvonen, E
    Nousiainen, T
    Koistinen, P
    Volin, L
    Remes, K
    BONE MARROW TRANSPLANTATION, 2006, 37 : S44 - S44
  • [43] Stem cell transplantation for chronic lymphocytic leukaemia. An updated review
    Dreger, P
    Schmitz, N
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 3 - 8
  • [44] Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    P Dreger
    N von Neuhoff
    R Kuse
    R Sonnen
    B Glass
    L Uharek
    R Schoch
    H Löffler
    N Schmitz
    British Journal of Cancer, 1998, 77 : 2291 - 2297
  • [45] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia
    Perz, JB
    Sanz, J
    Ghorashian, S
    Chaidos, A
    Kaeda, J
    Szydlo, RM
    Marin, DC
    Olavarria, E
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 : S227 - S227
  • [46] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN CHEMOTHERAPY REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Aljitawi, O. S.
    Krishnana, A.
    Nademance, A.
    Palmer, J.
    Alvarnas, J.
    Cai, J. -L.
    Kirschbaum, M.
    Kogut, N.
    Nakamura, R.
    Popplewell, L.
    Sarkodee-Adoo, C.
    Schriber, J.
    Zain, J.
    Parker, F.
    Forman, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 109 - 109
  • [47] Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience
    Michallet, M
    Brand, R
    Dreger, P
    Milligan, DW
    Esteve, J
    Kimby, E
    Gratwohl, A
    Apperley, J
    Van Biezen, A
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 2001, 27 : S31 - S31
  • [48] Outcome of immunotherapeutic rescue strategies for clinical relapse of high-risk chronic lymphocytic leukemia (CLL) in patients after allogeneic hematopoietic stem cell transplantation (HSCT)
    Hahn, M.
    Dietrich, S.
    Herth, I.
    Hegenbart, U.
    Walter, E.
    Rieger, M.
    Stadtherr, P.
    Bondong, A.
    Ho, A. D.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 51 - 51
  • [49] Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Bociek, G
    Greer, JP
    Wu, CD
    Kollath, JP
    Weisenburger, DD
    Kessinger, A
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 717 - 722
  • [50] Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia
    Oyekunle, A.
    Klyuchnikov, E.
    Kroeger, N.
    Zabelina, T.
    Ayuk, F.
    Wolschke, C.
    Bernhardt, F.
    Mueller, I.
    Zander, A.
    Bacher, U.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S363 - S363
12345